Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity.

Front Oncol · 2022 · PMC9196183 · PMID 35712518

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a nonsignificant trendp = 0.10so close (0.05 < p ≤ 0.1)

There was no increase in side effects with the use of aspirin but there was a nonsignificant trend towards greater toxicity with concurrent ICI and aspirin use (41% with vs 25% without; OR 2.19, p = 0.10).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.